Samsara BioCapital’s Allakos ALLK Stock Holding History

Samsara BioCapital’s Portfolio ALLK Stock Details ALLK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-168,200	Closed	-$1.65M	–	58
2021 Q4	$1.65M	Hold	168,200	–	–	0.32%	39
2021 Q3	$17.8M	Buy	168,200 +85,200	+103%	+$7.61M	2.79%	11
2021 Q2	$7.09M	Hold	83,000	–	–	0.87%	23
2021 Q1	$9.53M	Buy	+83,000	New	+$10.5M	1.76%	15

Samsara BioCapital's ALLK Position: Q2 2025 in Review

Samsara BioCapital sold out of Allakos (ALLK) in Q2 2025, closing a stake of 172,089 shares — an estimated $39.2K sold.

Samsara BioCapital first reported a position in ALLK in Q4 2018 and held it in 26 quarters. The position peaked at $24M in Q4 2018. 0 funds tracked by Wall St. Rank hold ALLK as of Q2 2025.

Samsara BioCapital reported no remaining Allakos position as of Q2 2025 after selling out during the quarter.
Samsara BioCapital sold 172,089 Allakos shares in Q2 2025, an estimated $39.2K.
Samsara BioCapital first reported a position in Allakos in Q4 2018 and held it in 26 quarters.
Samsara BioCapital's Allakos position peaked at $24M in Q4 2018.
0 funds tracked by Wall St. Rank held Allakos as of Q2 2025.

Based on Samsara BioCapital's 13F filing for Q2 2025, filed 14 Aug 2025.